Q2 2023 Holdings
Filed 2023-08-14 | 32 holdings | $971.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvalent Inc(NUVL) | COM | 670703107 | $150.9M | 3,577,267 | 15.5% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $124.5M | 10,473,913 | 12.8% |
| Springworks Therapeutics Inc | COM | 85205L107 | $80.8M | 3,081,307 | 8.3% |
| Pharvaris N V(PHVS) | COM | N69605108 | $73.7M | 4,868,784 | 7.6% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $59.2M | 1,332,548 | 6.1% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $41.5M | 2,305,558 | 4.3% |
| Savara Inc(SVRA) | COM | 805111101 | $37.1M | 11,622,598 | 3.8% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $35.3M | 3,400,000 | 3.6% |
| Natera Inc(NTRA) | COM | 632307104 | $34.1M | 700,197 | 3.5% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $31.2M | 2,415,000 | 3.2% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $31.0M | 15,960,588 | 3.2% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $28.6M | 3,000,000 | 2.9% |
| Mersana Therapeutics Inc | COM | 59045L106 | $28.5M | 8,663,673 | 2.9% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $27.4M | 2,500,000 | 2.8% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $25.8M | 2,000,000 | 2.7% |
| Annexon Inc(ANNX) | COM | 03589W102 | $20.1M | 5,701,926 | 2.1% |
| Eqrx Inc | COM | 26886C107 | $18.6M | 10,003,573 | 1.9% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $18.2M | 1,822,883 | 1.9% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $16.4M | 3,130,422 | 1.7% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $15.5M | 1,431,058 | 1.6% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $14.3M | 1,408,901 | 1.5% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $9.3M | 2,485,638 | 1.0% |
| Rapid Micro Biosystems Inc(RPID) | CLASS A COM | 75340L104 | $8.4M | 8,434,560 | 0.9% |
| Nautilus Biotechnology Inc(NAUT) | COM | 63909J108 | $7.7M | 2,000,000 | 0.8% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $7.4M | 2,805,413 | 0.8% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $6.7M | 2,124,694 | 0.7% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $6.4M | 1,921,790 | 0.7% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $4.5M | 1,642,210 | 0.5% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $3.1M | 640,631 | 0.3% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $2.6M | 934,898 | 0.3% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $2.0M | 1,937,207 | 0.2% |
| Newamsterdam Pharma Company | *W EXP 11/22/202 | N62509117 | $209.0K | 100,000 | 0.0% |